Abstract Purpose of Review Measurable residual disease (MRD) is an important monitoring
parameter that can help predict survival outcomes in acute lymphoblastic leukemia (ALL) …

Various factors are effective in the development of minimal residual disease (MRD), one of
which is MicroRNAs (miRNAs). miRNAs and their dysfunction in gene expression have …

Simple Summary Advances in immunophenotyping and molecular techniques have allowed
for the development of more sensitive diagnostic tests in acute leukemia. These techniques …

Introduction Follow‐up after allogeneic transplantation in acute myeloid leukaemia (AML) is
guided by measurable residual disease (MRD) testing. Quantitative polymerase chain …

Simple Summary Leukemia stem cells (LSCs) are rare cell populations present in acute
myeloid leukemia (AML) that are resistant to chemotherapy and cause disease relapse in …

Abstract Background Droplet digital PCR (ddPCR) is widely applied to monitor measurable
residual disease (MRD). However, there are limited studies on the feasibility of ddPCR-MRD …

Leukemia pada anak-anak di Indonesia menjadi perhatian serius dalam bidang kesehatan
karena variasi tingkat kelangsungan hidup dan dampak negatif dari pengobatan. Penelitian …

Introduction Despite the prognosis of patients affected by acute myeloid leukemia (AML)
improved in the last decade, most patients relapse. Maintenance therapy after a …

PURPOSE AML is a heterogeneous hematologic malignancy. Region-specific
recommendations for AML management can enhance patient outcomes. This article aimed …

Background FLT3-ITD mutations occur in 45–50% of cytogenetically normal AML patients.
Conventional fragment analysis using capillary electrophoresis is routinely used to …